Squarepoint
AKYA

Squarepoint’s Akoya BioSciences AKYA Stock Holding History

Squarepoint’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-52,159
Closed -$72.5K – 4443
2025
Q1 		$72.5K Buy
+52,159
New +$114K ﹤0.01% 4291
2024
Q3 		– Sell
-65,949
Closed -$154K – 4066
2024
Q2 		$154K Sell
65,949
-72,329
-52% -$231K ﹤0.01% 3723
2024
Q1 		$649K Buy
138,278
+41,346
+43% +$215K ﹤0.01% 2870
2023
Q4 		$473K Sell
96,932
-30,287
-24% -$126K ﹤0.01% 3043
2023
Q3 		$592K Buy
127,219
+87,863
+223% +$505K ﹤0.01% 2666
2023
Q2 		$291K Buy
39,356
+27,403
+229% +$183K ﹤0.01% 2994
2023
Q1 		$97.8K Buy
+11,953
New +$125K ﹤0.01% 2974

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Squarepoint's AKYA Position: Q2 2025 in Review

Squarepoint sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 52,159 shares — an estimated $72.5K sold.

Squarepoint first reported a position in AKYA in Q1 2023 and held it in 7 quarters. The position peaked at $649K in Q1 2024. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

  • Squarepoint reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 52,159 Akoya BioSciences shares in Q2 2025, an estimated $72.5K.
  • Squarepoint first reported a position in Akoya BioSciences in Q1 2023 and held it in 7 quarters.
  • Squarepoint's Akoya BioSciences position peaked at $649K in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.